In a filing, Anavex Life Sciences Corporation revealed its President and CEO MISSLING CHRISTOPHER U unloaded Company’s shares for reported $0.37 million on Mar 28 ’24. In the deal valued at $5.11 per share,73,380 shares were sold. As a result of this transaction, MISSLING CHRISTOPHER U now holds 1,250,210 shares worth roughly $5.29 million.
Then, MISSLING CHRISTOPHER U sold 268,000 shares, generating $2,139,310 in total proceeds. Upon selling the shares at $7.98, the President and CEO now owns 1,018,210 shares.
Cantor Fitzgerald downgraded its Anavex Life Sciences Corporation [AVXL] rating to a Neutral from a an Overweight in a research note published on December 06, 2022; the price target was decreased to $11 from $16. A number of analysts have revised their coverage, including Berenberg’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. BTIG Research began covering AVXL with “Buy” recommendation on September 23, 2021. H.C. Wainwright maintained its rating on December 16, 2020. It rated AVXL as “a Buy”.
Price Performance Review of AVXL
On Monday, Anavex Life Sciences Corporation [NASDAQ:AVXL] saw its stock fall -1.51% to $4.23. Over the last five days, the stock has lost -3.64%. Anavex Life Sciences Corporation shares have fallen nearly -54.56% since the year began. Nevertheless, the stocks have fallen -47.58% over the past one year. While a 52-week high of $10.45 was reached on 01/02/24, a 52-week low of $4.16 was recorded on 04/12/24. SMA at 50 days reached $5.09, while 200 days put it at $6.72. A total of 1.09 million shares were traded, compared to the trading of 1.13 million shares in the previous session.
Levels Of Support And Resistance For AVXL Stock
The 24-hour chart illustrates a support level at 4.15, which if violated will result in even more drops to 4.07. On the upside, there is a resistance level at 4.34. A further resistance level may holdings at 4.45. The Relative Strength Index (RSI) on the 14-day chart is 36.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.27%. Stochastics %K at 15.63% indicates the stock is a buying.
The most recent change occurred on September 28, 2020 when Ladenburg Thalmann began covering the stock and recommended ‘”a Buy”‘ rating along with a $12 price target.
